About Triphase Pharmaceuticals
Data last updated:
Triphase Pharmaceuticals is a company based in Mysuru (India). It operates as a B2B. The company has 12 employees as of March 31, 2022. Triphase Pharmaceuticals has completed 1 acquisition, including Nereus Pharmaceuticals. Triphase Pharmaceuticals operates in a competitive market with competitors including Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and One bio, among others.
- Headquarter Mysuru, India
- Employees 12 as on 31 Mar, 2022
- SectorsHealthcare
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Triphase Pharmaceuticals Private Limited
- Date of Incorporation 01 Jun, 2006
- Jurisdiction Mysore, Karnataka, India
- Annual Revenue$7.29 K (USD)233.15as on Mar 31, 2022
- Net Profit-$406.5 K (USD)-50.91as on Mar 31, 2022
- EBITDA-$278.47 K (USD)-46.19as on Mar 31, 2022
- Latest Funding RoundNot available
- InvestorsNot available
- Employee Count12
as on Mar 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Triphase Pharmaceuticals
Detailed funding history for Triphase Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Triphase Pharmaceuticals
Triphase Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nereus Pharmaceuticals.
Investment portfolio details for Triphase Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
Develop therapeutics for the treatment of oncology, infectious diseases and inflammation | Locked | Locked | 1998 | Locked |
Complete acquisition details for Triphase Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Triphase Pharmaceuticals
Detailed financials for Triphase Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Triphase Pharmaceuticals Comparisons
Peer comparison for Triphase Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Triphase Pharmaceuticals
Triphase Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and One bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Pendulum is focused on developing advanced probiotic solutions. | |
| Locked | Locked | Locked | Synbiotic supplements and fermented products for gut health are provided. | |
| Locked | Locked | Locked | Branded coconut water and probiotic beverages are manufactured and marketed. | |
| Locked | Locked | Locked | Microbial strains are developed for treating human metabolic diseases. | |
| Locked | Locked | Locked | Online tools for partner management and opportunity screening. | |
| Locked | Locked | Locked | Probiotic strains for health solutions are developed and manufactured. |
Detailed competitors of Triphase Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Triphase Pharmaceuticals
Complete news archive for Triphase Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triphase Pharmaceuticals
Triphase Pharmaceuticals is headquartered in Mysuru, India. It is registered at Mysuru, Karnataka, India.
As of Mar 31, 2022, the latest employee count at Triphase Pharmaceuticals is 12.
Annual revenue of Triphase Pharmaceuticals is $7.29K as on Mar 31, 2022.
Triphase Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, nutraceuticals, and probiotic products. Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Triphase Pharmaceuticals's top competitors include The Good Bug, Pendulum and OptiBiotix Health.
Triphase Pharmaceuticals has made 1 acquisition, including Nereus Pharmaceuticals.